Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19424051 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)
Conditions: HIV Infections;   HIV-Associated Lipodystrophy Syndrome
Interventions: Drug: Lopinavir/ritonavir + zidovudine + lamivudine;   Drug: Lopinavir/ritonavir + nevirapine

Indicates status has not been verified in more than two years